OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer vaccines: from an immunology perspective
Shania Makker, Charlotte Galley, Clare L. Bennett
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 10
Shania Makker, Charlotte Galley, Clare L. Bennett
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Are we getting closer to a successful neoantigen cancer vaccine?
Karen Manoutcharian, Goar Gevorkian
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101254-101254
Closed Access | Times Cited: 5
Karen Manoutcharian, Goar Gevorkian
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101254-101254
Closed Access | Times Cited: 5
Short Peptides as Powerful Arsenal for Smart Fighting Cancer
Joanna Bojarska, Wojciech M. Wolf
Cancers (2024) Vol. 16, Iss. 19, pp. 3254-3254
Open Access | Times Cited: 4
Joanna Bojarska, Wojciech M. Wolf
Cancers (2024) Vol. 16, Iss. 19, pp. 3254-3254
Open Access | Times Cited: 4
In situ vaccine “seeds” for enhancing cancer immunotherapy by exploiting apoptosis-associated morphological changes
Binghua Wang, Rong Guo, Fujun Qiu, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 757-767
Closed Access
Binghua Wang, Rong Guo, Fujun Qiu, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 757-767
Closed Access
Cancer Vaccines
Matjaž Zorko, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 213-229
Closed Access
Matjaž Zorko, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 213-229
Closed Access
Identification of new immune target and signaling for cancer immunotherapy
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access
New insights for the development of efficient DNA vaccines
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
Cytokine-overexpressing dendritic cells for cancer immunotherapy
Joonsu Han, Hua Wang
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 2
Joonsu Han, Hua Wang
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 2
Recent Developments of Vaccines as a Precision Medicine Approach to Cancer Immunotherapy
Joseph F. Murphy
Cancer Screening and Prevention (2024) Vol. 3, Iss. 2, pp. 113-117
Open Access
Joseph F. Murphy
Cancer Screening and Prevention (2024) Vol. 3, Iss. 2, pp. 113-117
Open Access
Exploring Cancer Immunotherapy and the Promise of Cancer Vaccine
Pavitra Ranawat, Bhupinder Sharma, Parvinder Singh, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 265-310
Closed Access
Pavitra Ranawat, Bhupinder Sharma, Parvinder Singh, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 265-310
Closed Access
Broad applicability of the Goldspire™ platform for the treatment of solid tumors
Jenny Zilberberg, Christopher Uhl, Charles Scott, et al.
Clinical Immunology (2024), pp. 110373-110373
Open Access
Jenny Zilberberg, Christopher Uhl, Charles Scott, et al.
Clinical Immunology (2024), pp. 110373-110373
Open Access
